Comparison of Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention in Patients with Diabetes
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11936-015-0377-y.pdf
Reference68 articles.
1. Abdallah MS, Wang K, Magnuson EA, et al. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. JAMA. 2013;310(15):1581–90.
2. Authors/Task Force M, Windecker S, Kolh P, et al. ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619.
3. Bangalore S, Kumar S, Fusaro M, et al. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ. 2012;345:e5170.
4. Bangalore S, Toklu B, Amoroso N, et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ. 2013;347:f6625. A meta-analysis of 126 randomized controlled comparison trials of all available stents showed that 2nd generation DES, especially CoCr EES, is the most efficacious and safe stent in the current market even when compared to 1st generation DES.
5. Bangalore S, Toklu B, Feit F. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap? Circulation. Cardiovasc Interv. 2014;7(4):518–25. A mixed treatment analysis that included 68 randomized controlled trials enrolling 24015 diabetic patients and 71595 patient-years of follow-up revealed that the clinical efficacy gap between CABG and PCI has narrowed with newer generations of PCI modality as CABG was separately compared to POBA to BMS to 1st generation DES. Furthermore, an indirect analysis comparing CABG to 2nd generation DES, especially cobalt-chromium everolimus-eluting stent, showed similar outcomes in death and MI; CABG was associated with numerically increased stroke events whereas PCI with cobalt-chromium everolimus-eluting stent associated with numerically increased repeat revascularization.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of Diabetes Mellitus on Outcomes after High-Risk Interventional Coronary Procedures;Journal of Clinical Medicine;2020-10-25
2. BARI 2D: A Reanalysis Focusing on Cardiovascular Events;Mayo Clinic Proceedings;2019-11
3. Diabetes und Revaskularisation;Aktuelle Kardiologie;2018-08
4. Managing Chronic Coronary Artery Disease in Patients with Diabetes;Chronic Coronary Artery Disease;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3